Kinapse appoints a new CEO
This article was originally published in Scrip
The UK information processing and business consultancy, Kinapse, has appointed Shalabh Kumar chief executive officer. He is currently COO and a board member. Mr Kumar succeeds Andy Black, who continues on the board and has a new role, global head of client services.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
France’s fledgling biotech Dynacure has pulled together a series C funding round to support its ongoing Phase I/II study of an antisense molecule for an ultrarare myopathy.